Aims Inflammatory stress plays a crucial role in the progression of diabetic nephropathy (DN). This study aimed to establish a novel inflamed animal model of DN and to evaluate its significance in DN. Methods Nondiabetic db/m mice and diabetic db/db mice were randomly divided into four groups: db/m, db/m+casein, db/db, and db/db+casein for eight weeks. Casein was subcutaneously injected to induce chronic inflammation. Body weight and albumin to creatinine ratio (ACR) in the urine were measured every week. The plasma levels of serum amyloid protein A (SAA) and tumour necrotic factor-α (TNF-α) were determined with the enzyme-linked immunosorbent assay. The morphological changes to the renal pathology and ultra-microstructures were checked by pathological staining and electron microscopy. Immunofluorescent staining and Western blotting were used to determine the protein expression of podocyte-specific molecules and inflammatory cytokines in kidneys.
Introduction
Diabetic nephropathy (DN) is a common and serious microvascular complication of diabetes mellitus that remains the foremost cause of end-stage renal disease (ESRD) in Western countries (1) . Unfortunately, the mechanisms leading to the development and progression of DN have not been completely elucidated. Therefore, it is very important to identify new pathogenic pathways that provide more opportunities for early diagnosis and therapy.
Chronic inflammation has been recognised as a key player in the pathogenesis of DN. Several lines of evidence from experimental and clinical studies have
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International Publisher demonstrated the participation of various inflammatory molecules and pathways in the setting of DN, such as acute phase reactants, inflammatory cytokines, adhesion molecules, and chemokines, which are activated by the metabolic, biochemical, and haemodynamic derangements known to exist in the diabetic kidney (2) . These inflammatory pathways lead to the activation and recruitment of macrophages and fibroblasts, which in turn initiate and sustain renal injury and fibrotic repair processes (3, 4) . Apart from the conventional control of blood glucose and blood pressure, targeting the specific pathways that lead to the activation of inflammation and the recruitment of fibroblasts could be a new and effective intervention in the management of DN. However, from a therapeutic perspective, only limited experience is available regarding the inhibition of inflammatory cytokines in DN. Therefore, further experimentation and clinical trials are necessary to examine the potential mechanisms of inflammation in aggravating DN.
An animal model is a useful tool for researchers to clarify the role of chronic inflammation in the pathogenesis of DN. At present, there are a variety of animal models used to study DN, including db/db mice, ob/ob mice, Otsuka Long-Evans Tokushima Fatty (OLETF) rats, and streptozotocin-induced rats. However, currently, there is no inflamed DN animal model for the investigation of the potential mechanisms of chronic inflammation in the progression of DN. Therefore, this study aimed to establish a novel inflamed DN animal model and to evaluate its significance in the research field of DN.
Materials and methods

Animal model
db/m mice and db/db mice, which were obtained from the Mode Animal Centre of Nanjing University (Nanjing, China), with a C57BL/KsJ genetic background, were studied using protocols approved by the Ethical Committee of Southeast University, following the latest version of the Declaration of Helsinki. Eight-week-old male nondiabetic db/m and diabetic db/db mice were randomly divided into four groups and subcutaneously injected every other day with 0.5 ml distilled water or 0.5 ml 10% casein (n=10 for each group): db/m, db/m+casein, db/db, and db/db+casein mice. The mice were fed with a normal chow diet containing 4% fat for eight weeks. Individual mice were placed in metabolic cages for 24-hour urine collection. At the end of the experimental period, blood samples were obtained from the right ventricle for the biochemical assays, and kidney samples were used for histological assessments.
Enzyme-linked immunosorbent assay
The serum levels of serum amyloid protein A (SAA, Invitrogen, USA) and tumour necrotic factor-α (TNF-α, R&D, USA) were measured by kits.
Biochemical assays
After the experimental period, the mice were euthanised, and blood samples were obtained from the right ventricle for biochemical analysis. The concentrations of blood glucose (BG), blood urea nitrogen (BUN), serum creatinine (Scr), triglyceride (TG), total cholesterol (TC), high-density lipoprotein (HDL) and low-density lipoprotein (LDL) were determined by automatic analysers (Hitachi, Japan). Albumin to creatinine ratio (ACR) was calculated by analysing the results of albumin and creatinine in the urine determined by enzyme-linked immunosorbent assay and clinical biochemistry assay.
Morphological analysis
Kidneys were either fixed in 10% buffered formalin and embedded in paraffin (light microscopy) or fixed in 2.5% glutaraldehyde and embedded in Lowicryl K4M resin (electron microscopy). Further procedures included periodic acid-Schiff (PAS) staining, trichrome-masson staining, and transmission electron microscopy.
Immunohistochemical staining
After deparaffinisation, sections were placed in citrate-buffered solution (pH 6.0) and heated for antigen retrieval. Subsequently, the sections were incubated with anti-mouse primary antibodies of TNF-α and MCP-1(Santa Cruz, USA) overnight at 4℃, followed by incubation with biotinylated secondary antibodies. Finally, a diaminobenzidine tetrahydrochloride substrate was used to develop the reaction. The results were observed under a light microscope (×400).
Immunofluorescent staining
The kidney sections were fixed with 4% paraformaldehyde and blocked in PBS containing 5% BSA (bovine serum albumin) for 60 minutes. The anti-mouse primary antibodies of a rabbit polyclonal antibody against Wilms' tumor-1 (WT-1) (Santa Cruz, USA) and a goat polyclonal antibody against nephrin (Santa Cruz, USA) were added and incubated overnight at 4℃. After a wash with PBS (pH 7.2), the sections were incubated with donkey anti-rabbit Fluor 555 and donkey anti-goat Fluor 488 secondary fluorescent antibodies (Invitrogen, USA), respectively. After washing, the slides were examined by laser confocal microscopy (×400).
Western blotting
Equal amounts of total proteins from the homogenates of partial kidney tissues in mice were separated by sodium dodecyl sulphate polyacrylamide gel electrophoresis. The membranes were blocked with blocking buffer for 1 hour at room temperature after gel transfer. The membranes were then incubated with anti-mouse primary antibodies, MCP-1, TNF-α, WT-1, or nephrin (Santa Cruz, USA), overnight at 4℃, followed by incubation with horseradish peroxidase-labelled secondary antibodies for 2 hours. Finally, signals were detected using enhanced chemiluminescence (GE Healthcare, USA).
Statistical analysis
All of the data are expressed as the means± standard deviation (SD) and processed with the SPSS software 13.0. Continuous variables were compared between the two groups with an independent-sample t test (where appropriate). A difference was considered significant if the P value was less than 0.05.
Results
Basic biochemical data in four groups of mice
As shown in Table 1 , there were significant decrease in Ccr and increases in BG, TG, TC, and Scr in db/db mice and db/db+casein mice compared with db/m mice and db/m+casein mice (P<0.05). In addition, although there was a similar body weight in db/db mice and db/db+casein mice at the beginning of the experiments, the casein-injected db/db mice showed a decreased body weight from the third week compared with db/db mice ( Fig. 1) . Fig. 1 The body weight changes in four groups of mice. Eight-week-old male nondiabetic db/m and diabetic db/db mice were randomly divided into four groups and subcutaneously injected with every other day 0.5 ml of distilled water or 0.5 ml of 10% casein (n=10 for each group): db/m, db/m+casein, db/db, and db/db+casein mice. The mice were fed with a normal chow diet containing 4% fat for eight weeks. The body weight changes were measured at each week. Values were represented as the means±SD *P<0.01 vs. db/db group. Fig. 2 The production of inflammatory cytokines in four groups of mice. Eight-week-old male nondiabetic db/m and diabetic db/db mice were randomly divided into four groups and subcutaneously injected with every other day 0.5 ml of distilled water or 0.5 ml of 10% casein (n=10 for each group): db/m, db/m+casein, db/db, and db/db+casein mice. The mice were fed with a normal chow diet containing 4% fat for eight weeks (A and B). At the end of the experimental period, the levels of SAA and TNF-α in the serum were measured by ELISA. Values were represented as the means±SD *P<0.01 vs. db/m group, **P<0.01 vs. db/db group.
Establishment of the inflamed DN mouse model
Our results demonstrated that the serum levels of SAA and TNF-α were both significantly increased in casein-injected db/m mice and db/db mice, compared with the controls (Fig. 2) . Furthermore, we checked the protein expression of TNF-α and MCP-1 in the kidneys of mice. Immunohistochemistry and Western blotting analysis showed that there was increased protein expression of TNF-α and MCP-1 in the kidneys of db/db mice compared with db/m mice (Fig. 3A-3C ). Interestingly, casein injection exacerbated the protein expression of TNF-α and MCP-1 in the kidneys of db/db mice, whereas there was no difference in the kidneys of db/m mice, regardless of the status of casein injection. In order to exclude the effects of infiltrated macrophages on the protein expression of TNF-α and MCP-1 in the kidneys of casein injected db/db mice, CD68 protein expression was checked by immunohistochemical staining. Results showed that there was no difference for CD68 protein expression between casein injected db/db and db/db mice (Fig.3D-3E ).
Inflammation increased proteinuria and exacerbated histopathological damage to the kidney in db/db mice As shown in Fig. 4 , ACR was progressively elevated in db/db mice from the fourth week. Interestingly, there was heavier excretion of urinary microalbumin in casein-injected db/db mice than in db/db mice from the fourth week. We further observed histopathological changes in the kidneys under inflammatory stress. PAS staining and Trichrome-masson staining demonstrated that glomerular hypercellularity, mesangial expansion, and collagen depositions were significantly increased in the kidneys of db/db mice compared with those of db/m mice ( Fig. 5A-5D ). Furthermore, casein injection deteriorates these changes in the kidneys of db/db mice. Transmission electron microscopy analysis showed that casein-injected db/db mice have a more significant degree of thickened glomerular basement membrane (GBM) mesangial expansion, and podocyte foot process fusion than db/db mice (Fig. 5E ). These findings suggested that chronic inflammation accelerated the progression of glomerulosclerosis in the db/db mice. However, the casein-injected db/m mice showed no obvious change.
Inflammation induced podocyte injuries in kidneys of db/db mice
WT-1 and nephrin are specific biomarkers of podocytes. As demonstrated by immunofluorescent staining, inflammatory stress significantly decreased the protein expression of WT-1 and nephrin in kidneys of casein-injected db/db mice compared with db/db mice, suggesting that inflammatory stress plays an important role in the deterioration of podocyte injuries in DN (Fig. 6A) . Western blotting analysis showed that inflammation markedly downregulated the protein expression of nephrin in the kidneys of casein-injected db/db mice compared with db/db mice ( Fig. 6B and 6C) , which was in accordance with the results from immunofluorescent staining. Fig. 3 Inflammation increased the protein expression of inflammatory cytokines in the kidneys of db/db mice. Eight-week-old male nondiabetic db/m and diabetic db/db mice were randomly divided into four groups and subcutaneously injected with every other day 0.5 ml of distilled water or 0.5 ml of 10% casein (n=10 for each group): db/m, db/m+casein, db/db, and db/db+casein mice. The mice were fed with a normal chow diet containing 4% fat for eight weeks. The protein expression of TNF-α and MCP-1 in the kidneys of the mice were measured by immunohistochemical staining (A, brown colour, original magnification×400) and Western blotting (B). The histogram represents the means ± SD of the densitometric scans of the protein bands from the mice per group, normalised by comparison with β-actin. *P<0.01 vs. db/m group, **P<0.01 vs. db/db group (C). The protein expression of CD68 in the kidneys of the mice was measured by immunohistochemical staining. The positive areas were stained brown in cross-sections of kidneys (D, original magnification, ×400). The values of semiquantitative analysis for the positive areas were expressed as the mean ±SD (n = 10 for each group). There was no difference among four groups. *P<0.01 vs. db/m group (E). Fig. 4 Inflammation increased the excretion of urinary microalmubin in db/db mice. Eight-week-old male nondiabetic db/m and diabetic db/db mice were randomly divided into four groups and subcutaneously injected with every other day 0.5 ml of distilled water or 0.5 ml of 10% casein (n=10 for each group): db/m, db/m+casein, db/db, and db/db+casein mice. The mice were fed with a normal chow diet containing 4% fat for eight weeks. Albumin to creatinine ratio (ACR) was determined at each week in the mice. Values were represented as the means±SD. *P<0.05 vs. db/m group, # P<0.05 vs db/db group. Fig. 5 Inflammation exacerbated the histopathological damage in the kidneys of db/db mice. Eight-week-old male nondiabetic db/m and diabetic db/db mice were randomly divided into four groups and subcutaneously injected with every other day 0.5 of ml distilled water or 0.5 ml of 10% casein (n=10 for each group): db/m, db/m+casein, db/db, and db/db+casein mice. The mice were fed with a normal chow diet containing 4% fat for eight weeks. The histopathological changes were assessed by PAS staining (A and B, red colour, original magnification ×400) and Masson's trichrome (C and D, blue colour, original magnification ×400). The values of semiquantitative analysis for the positive areas are expressed as the means±SD from mice at each group. * P<0.01 vs. db/m group, ** P< 0.05 vs. db/db group. The change in the glomerular ultramicrostructure was checked by electromicroscopy (E). Fig. 6 Inflammation exacerbated podocyte injury in the kidneys of db/db mice. Eight-week-old male nondiabetic db/m and diabetic db/db mice were randomly divided into four groups and subcutaneously injected with every other day 0.5 of ml distilled water or 0.5 of ml 10% casein (n=10 for each group): db/m, db/m+casein, db/db, and db/db+casein mice. The mice were fed with a normal chow diet containing 4% fat for eight weeks. The protein expression of WT-1 and nephrin were measured by immunofluorescent staining (A, brown colour, original magnification×400) and Western blotting (B). The histogram represented means ± SD of the densitometric scans of the protein bands from mice, normalised by comparison with β-actin.*P<0.01 vs. db/m group, **P<0.05 vs. db/db group (C).
Discussion
DN is chronic inflammatory disease (5) . The inflammation and activation of the immune system is closely associated with the development and progression of DN (6) (7) (8) , which is different from traditional infectious inflammations characterised by swelling, redness, pain and fever. This type of inflammation, which is activated by metabolic, biochemical, and haemodynamic disorders, is described as chronic, low-grade 'meta-flammation' (metabolically triggered inflammation) (9) and contributes to persistent kidney injuries and DN progression. Therefore, clarifying the mechanisms of the inflam-matory signal pathways involved in DN and preventing the progression of kidney injuries represent an enormous challenge for the researcher. However, currently, there is no reliable inflamed DN animal model. This study aimed to establish an inflamed DN animal model using db/db mice.
In our previous studies, we successfully established an inflamed animal model of non-alcoholic fatty liver disease using apolipoprotein E knockout mice fed with a Western diet and subcutaneously injected with 10% casein (10) . Casein, a protein extracted from milk, has often been used to induce chronic inflammation in recent years (10) (11) (12) (13) . The mechanism for casein-induced inflammation is not clear but could be correlated with the activation of the immune system and increased synthesis of liver acute-phase reactants. In this study, using db/db mice, a widely used type 2 diabetic model, we attempted to establish an inflamed DN model by subcutaneously injecting 10% casein. The db/db mouse, lacking the hypothalamic leptin receptor, is a model of type 2 diabetes mellitus that exhibits hyperglycaemia, hyperinsulinaemia, and hyperleptinaemia associated with the hyperphagia and obesity that manifest at 4-7 weeks after birth (14, 15) . The results of our pilot show that there was a high mortality rate in mice in conditions of daily casein injection, which was correlated with local skin infection and sudden death. However, when mice were treated with every other day casein injections, the mortality rate decreased to a very low level over the whole experimental period. Our results showed that the serum levels of SAA and TNF-α, both in casein-injected db/m mice and casein-injected db/db mice, were significantly increased, suggesting that systemic inflammation had successfully been induced. Interestingly, although the serum levels of inflammatory cytokines in casein-injected db/m mice were increased, the expression of inflammatory cytokines and histopathological changes of kidneys did not differ between casein-injected db/m mice and db/m mice. The CD68 protein expression in kidneys of diabetic mice was higher than that in non-diabetic mice, however, which was no difference between casein injected db/db mice and db/db mice, suggesting that the production of inflammatory cytokines in kidneys of casein injected db/db mice was not caused by infiltrated macrophages. Chronic inflammation aggravated the progression of kidney injuries in DN. From the fifth week on, there was a more significant proteinuria in casein-injected db/db mice compared with db/db mice, which was in accordance with the more marked protein expression of inflammatory cytokines, mesangial matrix expansion, and collagen deposition in the kidneys of casein-injected db/db mice compared with db/db mice. These findings suggested that chronic inflammation deteriorated the progression of DN and shortened the whole experimental period. This means that the intensity of the inflammation in casein-injected DN mice was higher than the intensity of the meta-flammation in DN mice alone, allowing for the observation of kidney injuries in DN using casein-injected db/db mice over a shorter experimental period and thus satisfying a rudimental requirement as a stable animal model.
We further assessed the effects of chronic inflammation on podocyte injuries in db/db mice. Our results demonstrated that chronic inflammation exacerbated podocyte injury, shown with the more significant effacement of podocyte foot processes, podocyte loss, and dysfunction of the slit diaphragm. The protein expression of WT-1 and nephrin, both specific biomarkers of podocytes, was significantly decreased in casein-injected db/db mice compared with db/db mice. These results, together with those of previous studies (16) (17) (18) , confirmed that inflammation was a key player in accelerating the development and progression of DN. The subcutaneous casein injection was safe and effective in the induction of an inflamed DN animal model and the deterioration of podocyte injuries in DN.
In conclusion, we successfully established an inflamed DN animal model. The kidney injuries of inflamed DN mice resembled the pathological changes of DN mice alone, whereas the intensity of inflammation and the degree of kidney injuries in inflamed DN mice were higher and more significant. Furthermore, the establishment of this inflamed DN animal model could be a useful tool for studying and understanding the mechanisms of inflammatory signal pathways in the progression of DN.
